METHOD FOR ASSESSING OVARIAN AROMATASE ACTIVITY

FIELD: medicine.SUBSTANCE: serum hormones are measured on the second day of the menstrual cycle prior to peroral administering letrozole aromatase inhibitor 10 mg and 48 hours after; pre-letrozole oestradiol and anti-Mullerian hormone and post-letrozole oestradiol are measured. An absolute decrease...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TARASOVA MARINA ANATOL'EVNA, SAVINA VALENTINA ANDREEVNA, NIKOLAENKOV IGOR' PAVLOVICH, POTIN VLADIMIR VSEVOLODOVICH, JARMOLINSKAJA MARIJA IGOREVNA, RULEV VIKTOR VIKTOROVICH, TIMOFEEVA EKATERINA MIKHAJLOVNA, TKACHENKO NATAL'JA NIKOLAEVNA, DENISOVA VALENTINA MIKHAJLOVNA
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine.SUBSTANCE: serum hormones are measured on the second day of the menstrual cycle prior to peroral administering letrozole aromatase inhibitor 10 mg and 48 hours after; pre-letrozole oestradiol and anti-Mullerian hormone and post-letrozole oestradiol are measured. An absolute decrease of post-letrozole oestradiol is determined, and an ovarian aromatase activity coefficient (K) is determined by formula. If K